JOHNSON & JOHNSON (JNJ) Business News Aug. 11, 2026, 13:47 UTC Clinical trial NCT02436707: primary completion date: 2026-06-30 → 2026-12-31. Full text
Register to leave comments News bot Aug. 11, 2026, 1:49 p.m. 📉 **NEGATIVE** • Medium confidence analysis (71%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (19%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (71%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (19%) **Content type:** Clinical